Ruthenium metalation of proteins: the X-ray structure of the complex formed between NAMI-A and hen egg white lysozyme

The mode of action of anticancer gold-based drugs: a structural perspective

(2013) Luigi Messori et al.   CHEMICAL COMMUNICATIONS

Biotransformations of Anticancer Ruthenium(III) Complexes: An X-Ray Absorption Spectroscopic Study

(2013) Aviva Levina et al.   CHEMISTRY-A EUROPEAN JOURNAL

Interaction of Anticancer Ruthenium Compounds with Proteins: High-Resolution X-ray Structures and Raman Microscopy Studies of the Adduct between Hen Egg White Lysozyme and AziRu

(2013) Alessandro Vergara et al.   INORGANIC CHEMISTRY

Peculiar Features in the Crystal Structure of the Adduct Formed between cis-PtI2(NH3)2 and Hen Egg White Lysozyme

(2013) Luigi Messori et al.   INORGANIC CHEMISTRY

Investigating the Ruthenium Metalation of Proteins: X-ray Structure and Raman Microspectroscopy of the Complex between RNase A and AziRu

(2013) Alessandro Vergara et al.   INORGANIC CHEMISTRY

Ruthenium-based complex nanocarriers for cancer therapy

(2012) Gaetano Mangiapia et al.   BIOMATERIALS

Next-Generation Anticancer Metallodrugs

(2012) Seiji Komeda et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Increasing the X-ray Diffraction Power of Protein Crystals by Dehydration: The Case of Bovine Serum Albumin and a Survey of Literature Data

(2012) Irene Russo Krauss et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

New insights into the chemistry of fac-[Ru(CO)3]2+ fragments in biologically relevant conditions: The CO releasing activity of [Ru(CO)3Cl2(1,3-thiazole)], and the X-ray crystal structure of its adduct with lysozyme

(2012) M.F.A. Santos et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Direct cryocooling of naked crystals: are cryoprotection agents always necessary?

(2011) Erika Pellegrini et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

REFMAC5 for the refinement of macromolecular crystal structures

(2011) Garib N. Murshudov et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Towards Improved Therapeutic CORMs: Understanding the Reactivity of CORM-3 with Proteins

(2011) T. Santos-Silva et al.   CURRENT MEDICINAL CHEMISTRY

Metal-based anti-diabetic drugs: advances and challenges

(2011) Aviva Levina et al.   DALTON TRANSACTIONS

Pyridine Analogues of the Antimetastatic Ru(III) Complex NAMI-A Targeting Non-Covalent Interactions with Albumin

(2011) Michael I. Webb et al.   INORGANIC CHEMISTRY

In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A

(2011) Zdeněk Trávníček et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Approaching tumour therapy beyond platinum drugs

(2011) A. Bergamo et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Exploring the mechanisms of metal­based pharmacological agents via an integrated approach

(2011) Angela Casini   JOURNAL OF INORGANIC BIOCHEMISTRY

CORM-3 Reactivity toward Proteins: The Crystal Structure of a Ru(II) Dicarbonyl−Lysozyme Complex

(2011) Teresa Santos-Silva et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin

(2011) Michael Groessl et al.   Metallomics

The X-ray Structure of the Adduct between NAMI-A and Carbonic Anhydrase Provides Insights into the Reactivity of this Metallodrug with Proteins

(2010) Angela Casini et al.   ChemMedChem

Organometallic ruthenium-based antitumor compounds with novel modes of action

(2010) Wee Han Ang et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Reactivity of an antimetastatic organometallic ruthenium compound with metallothionein-2: relevance to the mechanism of action

(2009) Angela Casini et al.   Metallomics

Recent developments in ruthenium anticancer drugs

(2009) Aviva Levina et al.   Metallomics